TheofilopoulosAN, DixonFJ.Murine models of SLE.Adv. Immunol.1985; 37: 269–390.
3.
GreensteinBD, de F BridgesE, FitzpatrickFTA.Aromatase inhibitors regenerate the thymus in aging male rats.Int J Immunopharmac1992; 14: 541–53.
4.
GreensteinBD.Effects of rat alpha-fetoprotein administration on estradiol free fraction, the onset of puberty, and neural and uterine estrogen receptors.Endocrinology1992; 130: 3184–90.
5.
GreensteinBD, ManderJ, FitzpatrickFTA.Effects of an aromatase inhibitor on testosterone-induced inhibition of thymus growth in immature female rats.J. Endocrinol1988; 119: 65–7.
6.
DowsettM, GossPE, PowlesTJ.Use of the aromatase inhibitor 4-hydroxyandrostenedione in post menopausal breast cancer: optimisation of therapeutic dose and route.Cancer Res1987; 47: 1957–61.
BlankM, MendlovicS, FrickeH, MozesE, TalalN, ShoenfieldY.Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice.J Rheumatol1990; 17: 311–7.
9.
DanielL, SouweineG, MonierJC, SaezS.Specific estrogen binding sites in human lymphoid cells and thymic cells.J Steroid Biochem1983; 18: 559–631.
10.
WeustenJJAM, BlankensteinMA, Gmeling-MeylingFHJ, ShuurmanHJ, KaterL, ThijssenJHH.Presence of estrogen receptors in human blood mononuclear cells and thymocytes.Acta Endocrinol (Copenh)1986; 112: 409–14.
11.
StimsonWH.Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset.Scand J Immunol1988; 28: 345–50.
12.
NovotnyEA, RavecheES, SharrowS, OttingerM, SteinbergAD.Analysis of thymocyte subpopulations following treatment with sex hormones.Clin Immunol Immunopathol1983; 23: 205–17.
13.
LahitaRG.Sex steroids and the rheumatic diseases.Arthritis Rheum1985; 28: 121–6.